Speech-Language Pathologists in Hideaway, TX Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Mrs. Mary Kathleen Kennedy, EDDSPED,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1613 Ginger Dr, Hideaway, TX 75771 Phone: 903-530-8169 |
News Archive
Warfarin treatment after aortic valve replacement reduces risk of cardiovascular death
Although current guidelines recommend 3 months of anticoagulation treatment after bioprosthetic aortic valve replacement surgery, a study that included more than 4,000 patients found that patients who had warfarin therapy continued between 3 and 6 months after surgery had a lower rate of cardiovascular death, according to a study in the November 28 issue of JAMA.
Effective management of neonatal abstinence syndrome requires coordinated ‘cascade of care'
Effective management of neonatal abstinence syndrome- withdrawal symptoms occurring in infants exposed to opioids in utero - requires a coordinated "cascade of care" from prevention through long-term follow-up, reports a study in Advances in Neonatal Care, official journal of the National Association of Neonatal Nurses. The journal is published in the Lippincott portfolio by Wolters Kluwer.
New clinical trial begins testing Epigem's instrument for detection, cure of rare anemias
Epigem today announced that one of its development instruments, MeChem, is being tested in a new clinical trial into the detection and cure of rare anemias. The company has filed two patents relating to the test methods and the associated system.
IRIN examines potential strategies to fight sleeping sickness in Tanzania's rural communities
"Tackling land-use conflicts around game parks must form part of the national strategy to stop the spread of Trypanosomiasis, or sleeping sickness, warn doctors fighting the disease in Tanzania," IRIN reports.
Dr. Jian-Dong Li receives $1.6 million to develop novel therapeutic targets to treat middle-ear infections
Dr. Jian-Dong Li, a professor and director of the Institute for Biomedical Sciences at Georgia State University and a Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received a five-year, $1.6 million federal grant to develop novel anti-inflammatory therapeutics against middle-ear infections.
› Verified 8 days ago